Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Do cirrhotic patients with a high MELD score benefit from TIPS?

Choe WH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sonography of hepatic hemangioma accompanied by arterioportal shunt

Choi SH, Kim KW, Hong GS, Lee SJ, Kim SY, Lee JS, Kim HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy

Seo AN, Kim H

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic venous pressure gradient: clinical use in chronic liver disease

Suk KT

Portal hypertension is a severe consequence of chronic liver diseases and is responsible for the main clinical complications of liver cirrhosis. Hepatic venous pressure gradient (HVPG) measurement is the best...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of portal hypertensive gastropathy and other bleeding

Chung WJ

A major cause of cirrhosis related morbidity and mortality is the development of variceal bleeding, a direct consequence of portal hypertension. Less common causes of gastrointestinal bleeding are peptic ulcers,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Allopurinol-induced DRESS syndrome mimicking biliary obstruction

Choi HG, Byun J, Moon CH, Yoon JH, Yang KY, Park SC, Han CJ

An 84-year-old man was admitted to our hospital with fever, jaundice, and itching. He had been diagnosed previously with chronic renal failure and diabetes, and had been taking allopurinol medication...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inactive hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study

Demirturk , Demirdal T

BACKGROUND/AIMS: The aims of the present study were to determine the outcomes of inactive hepatitis B virus (HBV) surface antigen (HBsAg) carriers over a 10-year study period and to elucidate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Kim JJ, Kim JH, Koo JK, Choi YJ, Ko SY, Choe WH, Kwon SY

BACKGROUND/AIMS: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved severe hepatopulmonary syndrome after liver transplantation in an adolescent with end-stage liver disease secondary to biliary atresia

Park TJ, Ahn KS, Kim YH, Kim H, Park UJ, Kim HT, Cho WH, Park WH, Kang KJ

Hepatopulmonary syndrome (HPS) is a serious complication of end-stage liver disease, which is characterized by hypoxia, intrapulmonary vascular dilatation, and liver cirrhosis. Liver transplantation (LT) is the only curative treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US

Min JH, Lim HK, Lim S, Kang TW, Song KD, Choi SY, Rhim H, Lee MW

BACKGROUND/AIMS: To determine the value of fusion imaging with contrast-enhanced ultrasonography (CEUS) and computed tomography (CT)/magnetic resonance (MR) images for percutaneous radiofrequency ablation (RFA) of very-early-stage hepatocellular carcinomas (HCCs) that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Yang JE, Park E, Lee HJ, Kang HJ, Kim KM, Yu E, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS

BACKGROUND/AIMS: The role of prostaglandin E2 (PGE2) in the modulation of cell growth is well established in colorectal cancer. The aim of this study was to elucidate the significance of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Jung HJ, Kim YS, Kim SG, Lee YN, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS

BACKGROUND/AIMS: Lipid profile and insulin resistance (IR) are associated with hepatitis C virus (HCV) and may predict the chronic hepatitis C (CHC) treatment response. The aim of this study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data

Kim HK, Kim YJ, Chung WJ, Kim SS, Shim JJ, Choi MS, Kim DY, Jun DW, Um SH, Park SJ, Woo HY, Jung YK, Baik SK, Kim MY, Park SY, Lee JM, Kim YS

BACKGROUND/AIMS: This retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (TIPS) procedure for managing portal hypertension in Koreans with liver cirrhosis. METHODS: Between January 2003 and July...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr